<DOC>
	<DOCNO>NCT00511719</DOCNO>
	<brief_summary>The purpose study compare kinetics biodynamics inhale Technosphere Insulin subcutaneous ( SC ) regular human insulin .</brief_summary>
	<brief_title>Bioavailability TechnosphereÂ® Insulin Versus Subcutaneous Regular Human Insulin Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Clinical Diagnosis type 2 diabetes mellitus Current regimen intensify insulin therapy ( define separate injection basal prandial insulin least three injection per day ) least six month prior study , include use longlasting insulin analogue glargine ( Lantus ) Patients must willing withhold insulin glargine 24 hour prior study drug dose 18 65 year old Body Mass Index &lt; 35kg/m2 HbA1c &lt; 9 % Nonsmoker least 2 year If medication ( oral antidiabetic agent ) addition insulin take screening , patient stable regimen define continue use dose medication period least 3 month immediately prior study enrollment FVC , FEV1 , VC &gt; 80 % expect normal Written inform consent Diabetes mellitus type 1 Current treatment ( within last 30 day ) oral antidiabetic agent Regular preprandial dos regular subcutaneous insulin 30 IU per meal Intake drug herbal preparation , evaluation investigator , may interfere interpretation clinical trial result know cause clinically relevant interference insulin action , glucose utilization recovery hypoglycemia ( eg , systematic steroid ) HIstory hypersensitivity drug drug similar chemical structure Treatment investigation drug within 3 month prior enrollment study Progressive fatal disease History malignancy within 5 year study entry ( basal cell carcinoma ) History drug alcohol abuse Evidence severe secondary complication diabetes ( neuropathy , nephropathy evidence creatinine &gt; 1.5 mg/dL female &gt; 1.8 mg/dL male , grade III IV retinopathy , severe peripheral vascular disease ) Evidence gastroparesis , orthostatic hypotension hypoglycemia unawareness ( autonomic neuropathy ) Myocardial infraction stroke within precede six month Positive hepatitis B ( hepatitis B surface antigen ) /or hepatitis C ( hepatitis C antibody ) serology /or positive HIV serology History presence clinically significant cardiovascular , hepatic ( evidenced ALT AST &gt; 3 time normal reference range ) , gastrointestinal , neurological , infectious disorder capable alter absorption , metabolism elimination drug , constitute significant risk factor take study medication Anemia ( hemoglobin concentration &lt; 11 g/dL female &lt; g/dL male ) Ongoing respiratory tract infection Pregnancy , lactation , intention become pregnant Women childbearing potential practicing inadequate birth control ( adequate birth control define use oral contraceptive , condom , diaphragm spermicide , intrauterine device , surgical sterilization ) Regular alcohol intake great 14 units*/week , patient unwilling stop alcohol duration study ( *1 unit=8 g ethanol , 1/4 liter beer 1 glass wine 1 measure spirit ) Investigator site personnel directly affiliate study immediate family . Immediate family define spouse , parent , child sibling , whether biological legally adopt</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>